Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure

Kezar Life Sciences, Inc. (KZR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Gifted 3,500,000 shares @ $0
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 4 COOPER GRAHAM K (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 4 Garner Elizabeth (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 4 Kauffman Michael (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 4 Wallace Courtney (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 4 Klearman Micki (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
02/07/2023 4 Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Sold 25,000 shares @ $7.146, valued at $178.7k
Sold 40,000 shares @ $6.883, valued at $275.3k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2023 4 Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Sold 50,000 shares @ $6.85, valued at $342.5k
01/25/2023 4 Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Sold 80,000 shares @ $6.81, valued at $544.8k
Sold 80,000 shares @ $6.98, valued at $558.4k
01/19/2023 4 Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Sold 6,114 shares @ $6.79, valued at $41.5k
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Mordwinkin Nicholas Michael (Chief Business Officer) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 185,000 options to buy @ $6.84, valued at $1.3M
01/10/2023 4 Kirk Christopher J. (President and CSO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 190,000 options to buy @ $6.84, valued at $1.3M
01/10/2023 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 195,000 options to buy @ $6.84, valued at $1.3M
01/10/2023 4 Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 580,000 options to buy @ $6.84, valued at $4M
01/10/2023 4 Henig Noreen (Chief Medical Officer) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 220,000 options to buy @ $6.84, valued at $1.5M
01/09/2023 4 Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Sold 12,162 shares @ $6.97, valued at $84.8k
Sold 3,000 shares @ $6.89, valued at $20.7k
01/05/2023 4 Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Sold 25,000 shares @ $7.1, valued at $177.5k
Sold 500 shares @ $7.1, valued at $3.6k
Sold 30,000 shares @ $7.17, valued at $215.1k
11/14/2022 4 Fowler John Franklin (CEO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Exercised 27,000 options to buy @ $0.9, valued at $24.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy